The mission of the Clinical Trial Office (CTO) is to provide comprehensive contracting, budget and trial initiation services for researchers and administrators to enhance their ability to achieve excellence in the clinical trial arena while adhering to University policies. To fulfill this purpose, the office supports clinical research endeavors through study initiation, monitoring and assessment.
In carrying out these responsibilities, the office staff demonstrates a strong commitment to exceptional service and the highest professional and ethical standards to assure the Integrity of the research effort.
The CTO provides regulatory services. Regulatory Services will include:
The CTO provides budget negotiation services with the sponsor on behalf of the investigator. Budget Preparation Services will include 1) assistance in contract negotiations for Industry Sponsored Studies, 2) assistance in contract negotiations for Investigator Initiated Studies with Industry Support. Generally, the following steps are managed:
Provide feasibility and needs assessments
These services are provided by a University biostatistician with a primary focus on Investigator initiated protocols that are applying for federal or pharmaceutical company funding. These services include:
Hours: Monday thru Friday 8:30 a.m.-5:00 p.m.
875 Ellicott Street Room 6040, Buffalo, NY 14203
Phone: (716) 881-8911
Phone: (716) 888-4050
Phone: (716) 888-4730
Security at the CTRC provided by Kaleida
Phone: (716) 859-5441
Escort service to your vehicle
Phone: (716) 859-5442
Phone: (716) 829-2752
Phone: (716) 829-2752
Director of HIPAA compliance
Phone: (716) 829-3172 X2
Radiation safety officer
Phone: (716) 829-3281
Environment Health and Safety
Phone: (716) 829-3301
Grant writing services
Phone: (716) 888-4777
The CTO has developed a process in which research projects will be handled within the department. Below is a flow chart depicting this process.
The purpose of this process is to streamline how clinical research is carried out from start to finish.
CTO: Clinical Trial Office
SPS: Sponsored Program Services
CDA: Confidential Disclosure Agreement
CTA: Clinical Trial Agreement
The Confidential Disclosure Agreement is usually the first form of contact from a Sponsor to an Investigator. This document must be reviewed and approved by Sponsored Program Services (SPS) before the potential Investigator receives any formal protocol from the sponsor.
Once you receive a CDA, please forward to the CTO, where we will initiate the process prior to forwarding to SPS for review and approval.
The Feasibility Questionnaire is a vital part of running a successful clinical trial. This document is sent to the PI by the sponsor and is to be completed through the CTO. This is a question/answer that will review the study’s goals and objectives versus the resources available to the PI including staffing, supplies, space requirements and patient population.
The CTO has the ability to access databases throughout affiliate institutions in order to conduct proper feasibility which allows for proper recruitment strategy evaluation.
The CTO works closely with the University Clinical Research Center (CRC) which will be an excellent resource to the Investigator in meeting your Clinical Trial needs.
Sponsored research requires the use and maintenance of a regulatory binder. The CTO will complete your regulatory submission to the Sponsor on your behalf, as well as generate the regulatory binder for you through the final IRB approval.
Once your study is approved, the binder will be given to you for your use and maintenance.
As a service provided by the CTO, the documents required for your UB HSIRB, CYIRB or SBSIRB submission are prepared on your behalf. These documents include but are not limited to the Core Data Form (application), Informed consent document and HIPAA waiver.
UB IRBs utilize IRBNet for all study related administrative work. As such, all Investigators and Co-Investigators are required to register through IRBNet to electronically sign documents, submissions, receive messages, submit amendments, continuing reviews, SAEs, etc.
The CTO will submit to the IRB on your behalf and manage your submission through final approval. You will be asked to provide information as needed to ensure accuracy and completeness. You will be asked to log in to the system once it has been uploaded for you, to read it over for accuracy and electronically sign it.
Documents must be received by the CTO by the 15th of the month to be submitted for the upcoming review cycle. Any submission received after the 15th of the month will be handled on a first come first serve basis and may or may not make that upcoming review cycle deadline based on workload. The submission sent to the CTO must include:
You can register quickly at https://www.irbnet.org/
Once final IRB approval is received, the documents will be added to the regulatory binder and handed over for use and maintenance.
To get your submission started, please contact:
One of the main functions of the CTO is budget negotiation. Budgets are always negotiable. Once the PI receives the sponsor’s budget, it should be forwarded to the CTO for the negotiation process to begin.
The goal of the CTO when developing the budget is to ensure that all costs associated with the clinical trial receive full reimbursement. This will allow all parties to receive proper payment while supporting the research program.
During budget negotiations, the CTO will act as the liaison between the PI and the sponsor.
Please forward all budgets to:
Evaluation of appropriate staffing is part of the feasibility process. Should it be identified that you will require staffing, please contact Pam Anderson at the CTO (888-4841) to set the hiring process in motion. The financial support for this will be built into your budget to cover the costs.
In addition, the CTO has Research study staff available to those investigators requiring assistance with study procedures. Once the study is recruiting, the cost for these staff will be billed to your study. This again will be built into your budget at the time of negotiation. This allows an investigator without an existing infrastructure to begin the study and actively recruit without having the funding up front.
These coordinators will work on a study by study basis and be shared among divisions.
Once the CTO has an approved CTA and budget as well as IRB Approval, the regulatory documents will be handed over to the PI for use and maintenance and the study team may begin their research.
The CTO has access to surrounding facility databases which can be used to search for patient population to assist in study recruitment. This service will serve as an asset in recruiting and assist in meeting study objectives and goals.
The PI and study team are responsible for the study conduct and adherence to the guidelines set out by the sponsor. However; the CTO will offer assistance where requested with invoicing, statistical analysis support as well as database review for patient recruitment purposes.
The CTO will meet with the investigator and/or study team on a quarterly basis to review study progress and recruitment to see if new strategies or opportunities should be considered. In addition, review of study enrollment logs will be conducted to ensure all costs are recovered from the sponsor.
If you believe you need assistance in any of these areas, please contact the CTO.
Once the study is ready for closure, the PI will contact the CTO in order to confirm that all study payments have been received. Additionally, the Clinical Trial Agreement and the budget will be reconciled to ensure all fees have been reimbursed including any hold backs.
Other helpful links: